eGFR = estimated glomerular filtration rate; GI = gastrointestinal; sCa = serum calcium.
References: 1. Brandi ML, Bilezikiak D, et al. Management of hypoparathyroidism: summary statement and guidelines. J Clin Endocrinol Metab. 2016;101(6):2273-2283. doi:10.1210/jc.2015-3907
2. Khan, AA, Bilezikian JP, Brandi ML, et al. Evaluation and management of hypoparathyroidism: summary statement and guidelines from the second international workshop. J Bone Miner Res. 2022;37(12):2568-2585. doi:10.1002/jbmr.4691
3. Bollerslev J, Rejnmark L, Zahn A, et al. European expert consensus of practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders (PARAT 2021). Eur J Endocrinol. 2022;186(2):R33-R63. doi:10.1530/EJE-21-1044
© April 2026 Ascendis Pharma Endocrinology, Inc. All rights
reserved.
Ascendis®, KnowHypoPara®, the Ascendis
Pharma logo and the company logo are trademarks owned by the
Ascendis Pharma group.
US-COMMPTH-2600119 04/26